DOJ Streamlines Health Care Fraud Self-Disclosures, Adds AI Detection — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- DOJ is creating a one-stop shop for health care companies to file voluntary self-disclosures, consolidating a process that previously required a separate filing at HHS, Deputy Assistant Attorney General Jacob Foster announced Thursday at the STAT Summit in Boston.
- Companies that report potential criminal misconduct can now receive limited caps on financial damages from both DOJ and HHS simultaneously under the new policy, rather than navigating two separate tracks.
- DOJ will deploy data analytics and artificial intelligence algorithms to surface fraud, with Foster naming providers billing for unneeded services, companies fabricating patient records, and health tech firms adding redundant diagnoses as target schemes.
- An Oct. 1 memo from Assistant Attorney General Colin M. McDonald directs the department to design new programs that "appropriately incentivize" whistleblowers to come forward, and investigators are already mining social media and news reports for leads on possible violations.
- Prosecutors will place "great weight" on factors like whether executives knew about or concealed fraud, whether a scheme ran for more than three years or across multiple states, and whether it affected taxpayer-funded programs, per new guidance.
- Foster framed the enforcement push as protection of Medicare's trust fund, which he warned "could run out" if fraud continues unchecked.
Why it matters: By merging DOJ and HHS self-disclosure tracks and lowering the friction for companies to come forward, the administration is simultaneously making it easier to confess and harder to hide — executives whose schemes run more than three years, cross state lines, or touch Medicare now face heightened individual scrutiny under new prosecutorial guidance.
Ask SkimNews
